How Long are Residual Newborn Screening Specimens Useful for Retesting when Stored in Suboptimal and Uncontrolled Conditions of Temperature and Humidity?
Open Access
- 1 January 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Journal of Inborn Errors of Metabolism and Screening
- Vol. 9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Short-Term Stabilities of 21 Amino Acids in Dried Blood SpotsClinical Chemistry, 2018
- Stability of Metabolites in Dried Blood Spots Stored at Different Temperatures Over A 2-Year PeriodBioanalysis, 2013
- Research Results: Preserving Newborn Blood SamplesScience Translational Medicine, 2012
- Immunoreactive trypsinogen (IRT) as a biomarker for cystic fibrosis: Challenges in newborn dried blood spot screeningMolecular Genetics and Metabolism, 2012
- Newborn Dried Blood Spot Screening: Residual Specimen Storage IssuesPediatrics, 2012
- The stability of markers in dried-blood spots for recommended newborn screening disorders in the United StatesClinical Biochemistry, 2011
- Long-Term Stability of Amino Acids and Acylcarnitines in Dried Blood SpotsClinical Chemistry, 2007
- Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogenJournal of Medical Screening, 2006
- Guidelines for the Retention, Storage, and Use of Residual Dried Blood Spot Samples after Newborn Screening Analysis: Statement of the Council of Regional Networks for Genetic ServicesBiochemical and Molecular Medicine, 1996
- Effect of Temperature on the Stability of Thyroid Stimulating Hormone in Dried Blood SpotsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1983